Ropes & Gray represented Sands Capital in leading $100 million in Series D financing for Cytovale, a commercial-stage medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated diseases.
Sands Capital is an active, long-term investor in leading innovative businesses globally. The firm managed more than $53.9 billion in client assets as of Sept. 30.
The team was led by venture capital & emerging companies partner Brad Flint.
LEGAL DESIRE NEWSLETTER
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.
